Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 4
1987 2
1988 1
1989 3
1990 4
1991 1
1993 3
1994 3
1995 7
1996 3
1997 5
1998 3
1999 4
2000 6
2001 4
2002 2
2003 2
2004 3
2005 1
2007 1
2008 1
2009 1
2010 4
2011 1
2016 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
DNA repair and cancer: lessons from mutant mouse models.
Ishikawa T, Zhang SS, Qin X, Takahashi Y, Oda H, Nakatsuru Y, Ide F. Ishikawa T, et al. Among authors: nakatsuru y. Cancer Sci. 2004 Feb;95(2):112-7. doi: 10.1111/j.1349-7006.2004.tb03190.x. Cancer Sci. 2004. PMID: 14965359 Free article. Review.
Komatsu Y, Nakajima R, Yasoda A, Nakatsuru Y, Arai H, Nakao K, Shigeno C. Komatsu Y, et al. Among authors: nakatsuru y. Clin Calcium. 2003 Sep;13(9):1188-92. Clin Calcium. 2003. PMID: 15775201 Japanese. No abstract available.
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.
Sato Y, Onozaki Y, Sugimoto T, Kurihara H, Kamijo K, Kadowaki C, Tsujino T, Watanabe A, Otsuki S, Mitsuya M, Iida M, Haze K, Machida T, Nakatsuru Y, Komatani H, Kotani H, Iwasawa Y. Sato Y, et al. Among authors: nakatsuru y. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4673-8. doi: 10.1016/j.bmcl.2009.06.084. Epub 2009 Jun 25. Bioorg Med Chem Lett. 2009. PMID: 19589677
Biological characterization of 2-aminothiazole-derived Cdk4/6 selective inhibitor in vitro and in vivo.
Hirai H, Shimomura T, Kobayashi M, Eguchi T, Taniguchi E, Fukasawa K, Machida T, Oki H, Arai T, Ichikawa K, Hasako S, Haze K, Kodera T, Kawanishi N, Takahashi-Suziki I, Nakatsuru Y, Kotani H, Iwasawa Y. Hirai H, et al. Among authors: nakatsuru y. Cell Cycle. 2010 Apr 15;9(8):1590-600. doi: 10.4161/cc.9.8.11306. Epub 2010 Apr 15. Cell Cycle. 2010. PMID: 20372067
Potent anti-tumor activity of a macrocycle-quinoxalinone class pan-Cdk inhibitor in vitro and in vivo.
Hirai H, Takahashi-Suziki I, Shimomura T, Fukasawa K, Machida T, Takaki T, Kobayashi M, Eguchi T, Oki H, Arai T, Ichikawa K, Hasako S, Kodera T, Kawanishi N, Nakatsuru Y, Kotani H, Iwasawa Y. Hirai H, et al. Among authors: nakatsuru y. Invest New Drugs. 2011 Aug;29(4):534-43. doi: 10.1007/s10637-009-9384-8. Epub 2010 Jan 19. Invest New Drugs. 2011. PMID: 20084424
71 results